Subsequently, the expression of KRT17 at various tumor pathological stages was analyzed, and the expression of KRT17 in most tumors at various pathological stages was higher than that in normal tissues, while the expression in normal tissues was higher than that in BRCA, KICH, and KIRC tissues at different stages. The gene discussed is KRT17; the disease is neoplasm.